A new tool to quickly diagnose bloodstream infections.
Diagnostic tool for assessment and tracking of microbial load in bloodstream infections
This study is testing a new, quick way to check for bloodstream infections using a special tool that gives results in just three hours, helping doctors treat patients faster and more effectively.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Helixbind, INC. NIH-funded |
| Lab location | 1 site (Boxborough, UNITED STATES) |
| Project ID | NIH-11099756 on NIH RePORTER |
What this research studies
This research focuses on developing a rapid diagnostic tool for bloodstream infections (BSIs) that can provide timely and accurate information about microbial load without the need for traditional blood culturing methods. The innovative approach utilizes a proprietary platform called RaPID, which analyzes whole blood samples directly and delivers results within three hours. This method aims to improve patient outcomes by enabling faster diagnosis and monitoring of treatment effectiveness, especially in cases where antimicrobial therapy is already in use.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients suspected of having bloodstream infections who require timely diagnosis and treatment.
Not a fit: Patients who do not have bloodstream infections or those who are not undergoing antimicrobial treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the time to diagnose bloodstream infections, leading to quicker treatment and improved survival rates for patients.
How similar studies have performed: Previous research has shown promising results with similar rapid diagnostic approaches, indicating potential for success in this novel application.
Where this research is happening
Boxborough, UNITED STATES
- Helixbind, INC. — Boxborough, United States (Active)
Researchers
- Principal investigator: Singer, Alon — Helixbind, INC.
- Study coordinator: Singer, Alon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.